The Digital Medicine Society (DiME) launched a new set of FDA-aligned digital measures to standardize how outcomes are tracked in pediatric rare disease trials. The framework aims to make trials faster and more efficient, giving researchers and drugmakers a practical roadmap for developing new therapies for children who often have no effective treatment options.
The Digital Medicine Society launched a new initiative — it seeks to establish a roadmap for how technology can support older adults who want to age safely at home. The project will bring together health systems, home health agencies and tech companies to develop products, policy guidance and case studies for scalable home care.
MedCity News was at the Vive conference and spoke with executives who shared their insights for the healthcare industry.
During a recent panel discussion, healthcare leaders highlighted that the true promise of technology lies in ensuring that tools are practical, trusted and widely usable for both patients and clinicians.
At DiMe’s Healthcare 2030 Summit, four healthcare leaders shared the innovations they believe could most improve care, from AI-driven solutions to reduce medical errors to stronger primary care relationships that could save billions.
Leaders from the VA and the ONC discussed how the future of U.S. healthcare will rely on both technology and creative problem-solving during a panel at DiMe’s Healthcare 2030 Summit.
AI hallucinations may not always be bad, according to a panel of experts at the MedCity INVEST Digital Health conference. Instead, they may let people know when there are gaps in the data.
Small practices play a critical role in healthcare delivery, but they cannot continue to absorb ever-increasing administrative demands without consequences.
A new initiative from the Digital Medicine Society aims to replace outdated mental health questionnaires with a set of shared digital measures that track things like patients’ sleep, activity and speech. By relying on real-time, quantitative insights, the project seeks to set a data-driven standard for evaluating the effectiveness of mental health treatments.
Digital therapeutics have shown how therapy can be delivered effectively through a digital interface, but the bankruptcy of Pear Therapeutics raised questions about whether these technologies can be commercially successful. A panel at the MedCity News INVEST Digital Health conference discussed the promise and pitfalls of these emerging technologies.
Insurers and employers are optimistic about the possibilities of virtual care, but they're not very enthusiastic about the care modality's larger influence on the healthcare industry, according to a recent report. Just 29% of employers and 34% of payers and benefits consultants said that virtual care will drastically change the way healthcare is provided and outcomes are achieved.
The nonprofit Digital Medicine Society is partnering with the likes of Google and the FDA to develop a free resource designed to help digital health startups navigate the regulatory process.
Arbiter’s Anjali Jameson on hospital and payer alignment.